Literature DB >> 21803523

Multilevel versus isolated endovascular tibial interventions for critical limb ischemia.

Nathan Fernandez1, Ryan McEnaney, Luke K Marone, Robert Y Rhee, Steven Leers, Michel Makaroun, Rabih A Chaer.   

Abstract

OBJECTIVE: Endovascular interventions for critical limb ischemia (CLI) continue to have variable reported results. The purpose of this study is to determine the effect of disease level and distribution on the outcomes of tibial interventions.
METHODS: A retrospective analysis of all tibial interventions done for CLI between 2006 and 2009 was performed. Outcomes of isolated tibial (group I) and multilevel interventions (group II) (femoropopliteal and tibial) were compared.
RESULTS: Endovascular interventions were utilized to treat 136 limbs in 123 patients for CLI: 54 isolated tibial (85% tissue loss), and 82 multilevel (80% tissue loss). Mean age and baseline comorbidities were comparable. The mean ankle-brachial index (ABI) was significantly lower prior to intervention in group II (0.53 vs 0.74; P < .001) but was similar postintervention (0.86 vs 0.88; P = NS). Wound healing or improvement was achieved in 69% in group I and in 87% in group II (P = .05). Mean overall follow-up was 12.6 ± 5.3 months. Time to healing was significantly longer in group I: 11.5 ± 8.8 months vs 7.7 ± 6.6 months (P = .03). Limb salvage was achieved in 81% of group I and 95% of group II (P = .05). The rate of reintervention was similar (13% vs 18%, P = NS), so was the rate of late surgical conversion (0% vs 6%; P = NS). Limb loss resulted from lack of conduit or initial target vessel for bypass and high-risk systemic comorbidities. Overall mortality rates were similar among both groups. An isolated tibial intervention was a predictor of limb loss at 1 year on multivariate analysis and resulted in a lower rate of limb salvage at 1 year compared with multilevel interventions. Additionally, despite comparable primary patency rates, there was improved secondary patency with multilevel interventions compared with the isolated tibial interventions. Predictors of limb loss in patients treated with isolated tibial intervention included multiple synchronous tibial revascularization (P = .005) and advanced coronary artery disease requiring revascularization (P = .005).
CONCLUSIONS: Adequate rates of limb salvage can be achieved in patients undergoing multilevel interventions for CLI, and improved patency is seen with multilevel compared to isolated tibial interventions. Patients with isolated tibial disease appear to have a higher incidence of limb loss secondary to poor initial pedal runoff, more extensive distal disease, and severe comorbidities precluding surgical bypass. Other therapeutic strategies should be considered in these patients, including primary amputation or pedal bypass when applicable.
Copyright © 2011 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21803523      PMCID: PMC3972254          DOI: 10.1016/j.jvs.2011.03.232

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  13 in total

Review 1.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

Authors:  J A Dormandy; R B Rutherford
Journal:  J Vasc Surg       Date:  2000-01       Impact factor: 4.268

2.  The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience.

Authors:  Toshifumi Kudo; Fiona A Chandra; Samuel S Ahn
Journal:  J Vasc Surg       Date:  2005-03       Impact factor: 4.268

3.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

4.  Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery.

Authors:  Donald T Baril; Robert Y Rhee; Justine Kim; Michel S Makaroun; Rabih A Chaer; Luke K Marone
Journal:  J Vasc Surg       Date:  2009-01       Impact factor: 4.268

5.  Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery.

Authors:  Toshifumi Kudo; Fiona A Chandra; Woo-Hyung Kwun; Bradley T Haas; Samuel S Ahn
Journal:  J Vasc Surg       Date:  2006-08       Impact factor: 4.268

6.  Contemporary results of angioplasty-based infrainguinal percutaneous interventions.

Authors:  James H Black; Glenn M LaMuraglia; Christopher J Kwolek; David C Brewster; Michael T Watkins; Richard P Cambria
Journal:  J Vasc Surg       Date:  2005-11       Impact factor: 4.268

7.  Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.

Authors:  Michael S Conte; Dennis F Bandyk; Alexander W Clowes; Gregory L Moneta; Lynn Seely; Todd J Lorenz; Hamid Namini; Allen D Hamdan; Sean P Roddy; Michael Belkin; Scott A Berceli; Richard J DeMasi; Russell H Samson; Scott S Berman
Journal:  J Vasc Surg       Date:  2006-04       Impact factor: 4.268

8.  Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions.

Authors:  Brian G DeRubertis; Peter L Faries; James F McKinsey; Rabih A Chaer; Matthew Pierce; John Karwowski; Alan Weinberg; Roman Nowygrod; Nicholas J Morrissey; Harry L Bush; K Craig Kent
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

9.  Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting?

Authors:  R E Parsons; W D Suggs; J J Lee; L A Sanchez; R T Lyon; F J Veith
Journal:  J Vasc Surg       Date:  1998-12       Impact factor: 4.268

10.  Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia.

Authors:  Marcello Romiti; Maximiano Albers; Francisco Cardoso Brochado-Neto; Anai Espinelli S Durazzo; Carlos Alberto Bragança Pereira; Nelson De Luccia
Journal:  J Vasc Surg       Date:  2008-04-18       Impact factor: 4.268

View more
  8 in total

Review 1.  Endovascular intervention for peripheral artery disease.

Authors:  Arun K Thukkani; Scott Kinlay
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

2.  Sex-Related Differences in the Outcomes of Endovascular Interventions for Chronic Limb-Threatening Ischemia: Results from the LIBERTY 360 Study.

Authors:  Stefanos Giannopoulos; Nicolas W Shammas; Ian Cawich; Cezar S Staniloae; George L Adams; Ehrin J Armstrong
Journal:  Vasc Health Risk Manag       Date:  2020-07-08

Review 3.  Treatment of infrapopliteal critical limb ischemia in 2013: the wound perfusion approach.

Authors:  Matthew C Bunte; Mehdi H Shishehbor
Journal:  Curr Cardiol Rep       Date:  2013-06       Impact factor: 2.931

Review 4.  Therapeutic angiogenesis in critical limb ischemia.

Authors:  Geoffrey O Ouma; Barak Zafrir; Emile R Mohler; Moshe Y Flugelman
Journal:  Angiology       Date:  2012-11-04       Impact factor: 3.619

Review 5.  New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease.

Authors:  Jesse Naghi; Ethan A Yalvac; Ali Pourdjabbar; Lawrence Ang; John Bahadorani; Ryan R Reeves; Ehtisham Mahmud; Mitul Patel
Journal:  Med Devices (Auckl)       Date:  2016-06-28

6.  Comparison of hybrid procedure and open surgical revascularization for multilevel infrainguinal arterial occlusive disease.

Authors:  Min Zhou; Dian Huang; Chen Liu; Zhao Liu; Min Zhang; Tong Qiao; Chang-Jian Liu
Journal:  Clin Interv Aging       Date:  2014-09-22       Impact factor: 4.458

7.  Clinical characteristics of patients with Rutherford category IV, compared with V and VI.

Authors:  Taketsugu Tsuchiya; Osamu Iida; Tatsuya Shiraki; Yoshimitsu Soga; Keisuke Hirano; Kenji Suzuki; Terutoshi Yamaoka; Yusuke Miyashita; Michihiko Kitayama; Koji Kajinami
Journal:  SAGE Open Med       Date:  2015-07-22

8.  Chronic limb threatening ischemia and diabetes mellitus: the severity of tibial atherosclerosis and outcome after infrapopliteal revascularization.

Authors:  Veerakaisa Koivunen; Markus Juonala; Kimmo Mikkola; Harri Hakovirta
Journal:  Scand J Surg       Date:  2020-11-23       Impact factor: 2.360

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.